Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Shefner

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Nature Medicine|November 22, 2011
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosisMerit Cudkowicz, Michael E Bozik, Evan W Ingersoll, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Mechanisms, models and biomarkers in amyotrophic lateral sclerosisMartin R Turner, Robert Bowser, Lucie Bruijn, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Infrastructure resources for clinical research in amyotrophic lateral sclerosisAlexander V Sherman, Amelie K Gubitz, Ammar Al-Chalabi, et al.
Annals of Neurology|May 28, 2023
Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral SclerosisMelanie Quintana, Benjamin R Saville, Matteo Vestrucci, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|May 18, 2012
Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosisJeremy Shefner, Jesse M Cedarbaum, Merit E Cudkowicz, et al.
JAMA Neurology|March 16, 2026
Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical TrialMerit Cudkowicz, Vivian E Drory, Adriano Chio, et al.
Annals of Neurology|December 22, 2021
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy DevelopmentSabrina Paganoni, James D Berry, Melanie Quintana, et al.
Muscle & Nerve|January 31, 2022
Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analysesRobert G Miller, Rongzhen Zhang, Paige M Bracci, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2024
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTDMichael Benatar, Terry D Heiman-Patterson, Johnathan Cooper-Knock, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|December 8, 2009
Toward more efficient clinical trials for amyotrophic lateral sclerosisMerit E Cudkowicz, Jon Katz, Dan H Moore, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Nature Medicine|November 22, 2011
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosisMerit Cudkowicz, Michael E Bozik, Evan W Ingersoll, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Mechanisms, models and biomarkers in amyotrophic lateral sclerosisMartin R Turner, Robert Bowser, Lucie Bruijn, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Infrastructure resources for clinical research in amyotrophic lateral sclerosisAlexander V Sherman, Amelie K Gubitz, Ammar Al-Chalabi, et al.
Annals of Neurology|May 28, 2023
Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral SclerosisMelanie Quintana, Benjamin R Saville, Matteo Vestrucci, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|May 18, 2012
Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosisJeremy Shefner, Jesse M Cedarbaum, Merit E Cudkowicz, et al.
JAMA Neurology|March 16, 2026
Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical TrialMerit Cudkowicz, Vivian E Drory, Adriano Chio, et al.
Annals of Neurology|December 22, 2021
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy DevelopmentSabrina Paganoni, James D Berry, Melanie Quintana, et al.
Muscle & Nerve|January 31, 2022
Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analysesRobert G Miller, Rongzhen Zhang, Paige M Bracci, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2024
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTDMichael Benatar, Terry D Heiman-Patterson, Johnathan Cooper-Knock, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|December 8, 2009
Toward more efficient clinical trials for amyotrophic lateral sclerosisMerit E Cudkowicz, Jon Katz, Dan H Moore, et al.
Pageof 6